BioSpace News Archive

BioMidwest

The Cardiac Risk of Chloroquine in Unapproved Indications

The current COVID-19 pandemic has impacted economic and social aspects of society around the globe.

March 26, 2020
·
2 min read
BioMidwest

Xeris Pharmaceuticals Announces $0 Copay for Gvoke™ PFS for People With Diabetes

Xeris Pharmaceuticals, Inc. announced a limited-time $0 copay offering for commercially eligible patients effective now through April 30, 2020 as a response to the COVID-19 pandemic.

March 26, 2020
·
6 min read
BioMidwest

Horizon Therapeutics plc Donates $1.5 Million to COVID-19 Response Efforts in Illinois and Other Impacted U.S. and Global Communities

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it, in partnership with Illinois Governor JB Pritzker, has provided $500,000 to the Illinois COVID-19 Response Fund and $500,000 to the Illinois Biotechnology Innovation Organization (iBIO) Institute’s COVID-19 Response Fund.

March 26, 2020
·
3 min read
Policy

Translate Bio Provides MRT5005 Program Updates

Translate Bio announced two updates related to its MRT5005 clinical development program in cystic fibrosis.

March 26, 2020
·
8 min read
BioMidwest

State of Texas and Senator Bryan Hughes Secure a Donation of Hydroxychloroquine Sulfate from Amneal Pharmaceuticals for Texas Patients

Amneal Pharmaceuticals, Inc., one of the largest U.S.-based generics manufacturers, and the State of Texas announced that they are responding to the national COVID-19 health emergency.

March 26, 2020
·
4 min read
Pharm Country

EpiVax Oncology Inc. Announces It Has Reduced the Timeline of Its Personalized Neoantigen Therapeutic Cancer Vaccine Process to Under Four Weeks

EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced it has reduced the timeline from biopsy to vaccine to under 4 weeks for its personalized neoantigen therapeutic cancer vaccines.

March 26, 2020
·
3 min read
Biotech Bay

DotLab, a molecular diagnostics company, announces the publication of the clinical validation study for its non-invasive test for endometriosis

The study was published in the American Journal of Obstetrics & Gynecology and is the first to validate biomarkers that reliably differentiate between endometriosis and other gynecologic pathologies with high accuracy

March 26, 2020
·
2 min read
BioMidwest

Smile Direct Club to Produce Face Shields for Medical Personnel Amidst COVID-19 PandemicFirst Shipment of 1,000 Shields Sent to St. Luke’s Boise Medical Center One Week after Smile Direct Club Announces Medical Supply 3D Printing Efforts

SmileDirectClub, the industry pioneer and first direct-to-consumer medtech platform for teeth straightening, has swiftly begun 3D printing medical-grade face shields for healthcare workers amidst the COVID-19 pandemic as concern surrounding availability of medical supplies grows.

March 26, 2020
·
2 min read
Ubiquitome’s COVID-19 Fast Test Device in Spotlight

Ubiquitome’s ability to deliver fast test results for COVID-19 is attracting global inquires and top talent keen to get it to countries in desperate need.

March 26, 2020
·
2 min read
Policy

Coronavirus (COVID-19) Update: Daily Roundup - March 26, 2020

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

March 26, 2020
·
3 min read